(Q47368648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Kathryn Pritchard-Jones

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

M E Kroll

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

17 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

2464-2469

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

The United Kingdom Children's Cancer Study Group--the first 20 years of growth and development.

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Adjuvant low dose radiation in childhood non-Hodgkin's lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Liver cancer in European children: incidence and survival, 1978-1997. Report from the Automated Childhood Cancer Information System project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Population-based survival after childhood lymphoblastic leukaemia in time periods corresponding to specific clinical trials from 1979 to 1998—a report from the Childhood Cancer Registry of Piedmont (Italy)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

International Classification of Childhood Cancer, third edition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

The Intergroup Rhabdomyosarcoma Study-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

How curable is relapsed Wilms' tumour? The United Kingdom Children's Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS183

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811513%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference